Nuon Adds $10M Debt, Options

Xconomy San Francisco — 

Nuon Therapeutics, the San Mateo, CA-based developer of treatments for autoimmune diseases, has raised $10 million in a financing composed of debt and option securities, according to a regulatory filing. The document doesn’t say who invested, although its board of directors includes representatives from Domain Associates, Frazier Healthcare Ventures, and GBS Venture Partners. Affymax CEO Arlene Morris is also a director.